MAYNE PHARMA COMMRCL
PharmaMAYNE PHARMA COMMRCL is a pharmaceutical company focused on Oncology.
MAYNE PHARMA COMMRCL's Key Drugs
MAYNE PHARMA COMMRCL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
MAYNE PHARMA COMMRCL's Recent FDA Approvals
New NDA/BLA approvals for MAYNE PHARMA COMMRCL over the last two years — novel drugs only, excluding generics and label supplements.
MAYNE PHARMA COMMRCL's Therapeutic Areas
MAYNE PHARMA COMMRCL's approved drugs and pipeline span 1 therapeutic area, led by Oncology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
MAYNE PHARMA COMMRCL's Top Competitors
MAYNE PHARMA COMMRCL's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
MAYNE PHARMA COMMRCL Pipeline Snapshot
Active clinical trials for MAYNE PHARMA COMMRCL across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2005-10-29
- Latest
- 2019-04-08
- Applications
- 1